Anti-VEGF and intraocular pressure

Comment

Aparna Rao. Br J Ophthalmol. 2011 Nov.

. 2011 Nov;95(11):1618.

doi: 10.1136/bjophthalmol-2011-300892. Epub 2011 Sep 19.

No abstract available

Comment on

Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents.
Good TJ, Kimura AE, Mandava N, Kahook MY. Good TJ, et al. Br J Ophthalmol. 2011 Aug;95(8):1111-4. doi: 10.1136/bjo.2010.180729. Epub 2010 Aug 11. Br J Ophthalmol. 2011. PMID: 20702430

Predictors of sustained intraocular pressure elevation in eyes receiving intravitreal anti-vascular endothelial growth factor therapy.
Yannuzzi NA, Patel SN, Bhavsar KV, Sugiguchi F, Freund KB. Yannuzzi NA, et al. Am J Ophthalmol. 2014 Aug;158(2):319-327.e2. doi: 10.1016/j.ajo.2014.04.029. Epub 2014 May 6. Am J Ophthalmol. 2014. PMID: 24814167 Clinical Trial.
Stroke and anti-VEGF therapy.
Ueta T, Mori H, Kunimatsu A, Yamaguchi T, Tamaki Y, Yanagi Y. Ueta T, et al. Ophthalmology. 2011 Oct;118(10):2093-2093.e2. doi: 10.1016/j.ophtha.2011.06.001. Ophthalmology. 2011. PMID: 21968167 No abstract available.
Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents.
Good TJ, Kimura AE, Mandava N, Kahook MY. Good TJ, et al. Br J Ophthalmol. 2011 Aug;95(8):1111-4. doi: 10.1136/bjo.2010.180729. Epub 2010 Aug 11. Br J Ophthalmol. 2011. PMID: 20702430
SUSTAINED ELEVATION OF INTRAOCULAR PRESSURE AFTER INTRAVITREAL ANTI-VEGF AGENTS: What Is the Evidence?
Dedania VS, Bakri SJ. Dedania VS, et al. Retina. 2015 May;35(5):841-58. doi: 10.1097/IAE.0000000000000520. Retina. 2015. PMID: 25905784 Review.
Anti vascular endothelial growth factor sequential therapy for neovascular age-related macular degeneration: is this the new deal?
Neri P, Mariotti C, Arapi I, Bambini E, Giovannini A. Neri P, et al. Curr Med Res Opin. 2012 Mar;28(3):395-400. doi: 10.1185/03007995.2012.662153. Epub 2012 Feb 14. Curr Med Res Opin. 2012. PMID: 22283373 Review.